The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
AUTOR(ES)
Thierry, F
RESUMO
The human papillomavirus 18 (HPV 18) long control region contains promoter and enhancer elements whose activity is restricted to several human cell lines of epithelial origin. This enhancer possesses a considerable constitutive activity which is further stimulated in the presence of the E2 trans-activating protein of bovine papillomavirus 1 (BPV1). Surprisingly the same BPV1 protein strongly repressed transcription from the genuine HPV18 enhancer-promoter DNA sequences. We suggest that binding of several molecules of E2 protein between the viral CAAT and TATA elements sterically hinders transcription initiation from this promoter, while the same DNA--protein assembly stimulates the SV40 promoter when cloned in an enhancer configuration upstream of this heterologous promoter. Unlike BPV1-E2 the homologous E2 gene product does not seem to strongly modulate viral transcription. Finally the BPV1-E2 gene product may repress some essential viral or host genes, since we failed to isolate HeLa cells expressing BPV1-E2.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=553796Documentos Relacionados
- The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
- cis- and trans-acting regulatory elements of the yeast URA3 promoter.
- Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.
- Three trans-acting regulatory functions control hydrogenase synthesis in Alcaligenes eutrophus.
- Genetic Localization and Biochemical Characterization of a TRANS-Acting Regulatory Effect in Drosophila
